Innovax Holdings Ltd

Austrax Holdings Limited is an investment holding company that provides financial and securities services in Hong Kong. Its offerings include corporate finance advisory (such as IPO sponsorship, financial and independent financial advisory, and compliance advisory), securities dealing and brokerage, securities financing (including margin financing for the public tranche of IPOs), asset management (fund and discretionary account management), futures contracts dealing and trading, and money lending (personal and corporate loans). It also acts as a placing or sub-placing agent, underwriter or sub-underwriter, or distributor for new share issues and placings of existing shares by listed companies; as coordinator, bookrunner, lead manager, underwriter, sub-underwriter, and distributor for IPOs; and as bookrunner, underwriter, and sub-underwriter for bond issues by listed or unlisted corporations. Formerly known as Innovax Holdings Limited, it changed its name to Austrax Holdings Limited in July 2026, was founded in 2014, and is headquartered in Central, Hong Kong.

Biotech & Genomic Medicine▲

Thai FDA registers 9-valent HPV vaccine and Botulinum Antitoxin

The Food and Drug Administration has registered a 9-valent cervical cancer vaccine and a bivalent botulinum antitoxin, both produced domestically for the first time in Thailand and ASEAN. The 9-valent HPV vaccine resulted from technology transfer cooperation with INNOVAX and received marketing authorization on 24 July 2026. The Botulinum Antitoxin was developed with the Queen Saovabha Memorial Institute of the Thai Red Cross Society and was registered on 6 July 2026, helping reduce import dependence and strengthening emergency preparedness. Prime Minister and Interior Minister Anutin Charnvirakul joined an event showcasing these achievements at Government House. The National Vaccine Institute has managed funding under the Science, Research and Innovation Promotion Fund since 2022 to elevate Thailand into an ASEAN vaccine security hub.

2680.HK ▲

Biotech & Genomic Medicine ▲

Money & Banking·25dRead more →